Author: Julien Riou; Anthony Hauser; Michel J Counotte; Christian L Althaus
Title: Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020 Document date: 2020_3_6
ID: mrsya6wz_27
Snippet: Our work has three important strengths. First, we use a mechanistic model for the transmission of, and mortality associated with SARS-CoV-2 infection which directly translates the data-generating mechanisms leading to biased observations of the number of deaths (because of right-censoring) and of cases (because of preferential ascertainment). Our model also accounts for the effect of control measures on disease transmission. We implemented the mo.....
Document: Our work has three important strengths. First, we use a mechanistic model for the transmission of, and mortality associated with SARS-CoV-2 infection which directly translates the data-generating mechanisms leading to biased observations of the number of deaths (because of right-censoring) and of cases (because of preferential ascertainment). Our model also accounts for the effect of control measures on disease transmission. We implemented the model in a Bayesian framework in order to propagate most sources of uncertainty from data and parameter 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- data generate mechanism and disease transmission: 1, 2
- death number and disease transmission: 1, 2, 3, 4, 5, 6, 7
- death number and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- death number and model implement: 1
- death number and preferential ascertainment: 1, 2
- death number and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- disease transmission and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- disease transmission and mechanistic model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- disease transmission and model implement: 1, 2, 3, 4, 5
- disease transmission and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- important strength and SARS infection: 1
- International license and mechanistic model: 1, 2, 3
- International license and model implement: 1
- International license and preferential ascertainment: 1, 2
- International license and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- mechanistic model and model implement: 1
- mechanistic model and SARS infection: 1, 2, 3, 4, 5
- model implement and SARS infection: 1
- preferential ascertainment and SARS infection: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date